(Reuters) - Abbott Laboratories on Wednesday raised its annual earnings forecast for the second time, citing strong demand for medical devices and pharmaceutical products.
The company now expects $5.17-$5.23 per share in adjusted earnings this year, compared to at least $4.90 per share it forecast earlier. The company had raised its outlook from at least $4.70 per share in July.
Abbott said it expects around $7.8 billion in COVID-19 test sales this year, with $500 million in the fourth quarter.
(Reporting by Leroy Leo and Bhanvi Satija in Bengaluru; Editing by Maju Samuel)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 106.7 USD | -0.16% | +1.39% | 185B | ||
